Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology.

  • Revenue in EUR (TTM)15.16bn
  • Net income in EUR228.00m
  • Incorporated2006
  • Employees33.58k
  • Location
    Evonik Industries AGRellinghauser Strasse 111ESSEN 45128GermanyDEU
  • Phone+49 20117701
  • Fax+49 2 011773475
  • Websitehttps://corporate.evonik.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EVKX.N:GER since
announced
Transaction
value
Thai Peroxide Co LtdDeal completed15 Dec 202315 Dec 2023Deal completed-1.48%--
Data delayed at least 15 minutes, as of Nov 22 2024 16:35 GMT.

Institutional shareholders

9.86%Per cent of shares held by top holders
HolderShares% Held
BlackRock Investment Management LLCas of 21 Nov 20249.29m1.99%
The Vanguard Group, Inc.as of 06 Nov 20248.85m1.90%
BlackRock Fund Advisorsas of 07 Nov 20244.60m0.99%
Norges Bank Investment Managementas of 30 Jun 20244.23m0.91%
DWS Investments (UK) Ltd.as of 07 Nov 20243.31m0.71%
BNP Paribas Asset Management Europe SASas of 07 Nov 20243.23m0.69%
Magallanes Value Investors SA SGIICas of 30 Jun 20243.19m0.69%
Boston Partners Global Investors, Inc.as of 31 Oct 20243.14m0.67%
Janus Henderson Investors UK Ltd.as of 31 Oct 20243.10m0.67%
Deka Investment GmbHas of 07 Nov 20243.00m0.65%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.